Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J.— 2022 年 7 月 12 日-- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today…
Jim Gallagher2022 年 7 月 12 日
Axendia: Improving Healthcare Outcomes by Rewarding Value, NOT Cost
This research examines the use of value-based communications to support the transition to fee-for-outcomes models…
Jim Gallagher2022 年 6 月 28 日
eCTD Submission Challenges
Industry standards are continually evolving, creating an environment of rapid change. With change comes challenges.…
Jim Gallagher2022 年 6 月 1 日
The Utility of Model-Informed Drug Development for Rare Diseases
Model-informed drug development (MIDD) is a network of closely integrated ecosystems that can seamlessly position…
Jim Gallagher2022 年 5 月 20 日
Certara Earns 2022 Great Place to Work Certification™
Princeton, NJ, 2022 年 5 月 17 日. Certara, Inc., a global leader in biosimulation, today announced that…
Jim Gallagher2022 年 5 月 17 日
CoAuthor Factsheet
Discover the key features and benefits of CoAuthor in this detailed fact sheet.
Jim Gallagher2022 年 5 月 16 日
Ask Me Anything: Career Opportunities in Regulatory & Medical Writing
Have you ever wondered what it would be like to be a Regulatory or Medical…
Jim Gallagher2022 年 5 月 12 日
Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator
Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical…
Jim Gallagher2022 年 5 月 9 日
